Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil Hartzoulakis

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|December 27, 2005
Aurora A and B kinases as targets for cancer: will they be selective for tumors?Nick Matthews, Cristina Visintin, Basil Hartzoulakis, et al.
Journal of Chemical Information and Modeling|July 12, 2007
Prediction of ion channel activity using binary kernel discriminationPeter Willett, David Wilton, Basil Hartzoulakis, et al.
Molecular Biology of the Cell|June 10, 2011
VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylationBirger Herzog, Caroline Pellet-Many, Gary Britton, et al.
Journal of Combinatorial Chemistry|May 11, 2004
Copper (II)-mediated arylation with aryl boronic acids for the N-derivatization of pyrazole librariesSharon Rossiter, Chi Kit Woo, Basil Hartzoulakis, et al.
Molecular Cancer Therapeutics|December 24, 2005
Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654AlaSean R McLean, Mali Gana-Weisz, Basil Hartzoulakis, et al.
Journal of Chemical Information and Modeling|November 13, 2013
Ligand- and structure-based virtual screening for clathrodin-derived human voltage-gated sodium channel modulatorsTihomir Tomašić, Basil Hartzoulakis, Nace Zidar, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2007
Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysisBasil Hartzoulakis, Sharon Rossiter, Herpreet Gill, et al.
The Journal of Biological Chemistry|March 4, 2006
Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signalingHaiyan Jia, Azadeh Bagherzadeh, Basil Hartzoulakis, et al.
Chembiochem : a European Journal of Chemical Biology|April 29, 2014
N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activityHaiyan Jia, Rehan Aqil, Lili Cheng, et al.
Journal of Medicinal Chemistry|February 16, 2010
Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interactionAshley Jarvis, Charles K Allerston, Haiyan Jia, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|December 27, 2005
Aurora A and B kinases as targets for cancer: will they be selective for tumors?Nick Matthews, Cristina Visintin, Basil Hartzoulakis, et al.
Journal of Chemical Information and Modeling|July 12, 2007
Prediction of ion channel activity using binary kernel discriminationPeter Willett, David Wilton, Basil Hartzoulakis, et al.
Molecular Biology of the Cell|June 10, 2011
VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylationBirger Herzog, Caroline Pellet-Many, Gary Britton, et al.
Journal of Combinatorial Chemistry|May 11, 2004
Copper (II)-mediated arylation with aryl boronic acids for the N-derivatization of pyrazole librariesSharon Rossiter, Chi Kit Woo, Basil Hartzoulakis, et al.
Molecular Cancer Therapeutics|December 24, 2005
Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654AlaSean R McLean, Mali Gana-Weisz, Basil Hartzoulakis, et al.
Journal of Chemical Information and Modeling|November 13, 2013
Ligand- and structure-based virtual screening for clathrodin-derived human voltage-gated sodium channel modulatorsTihomir Tomašić, Basil Hartzoulakis, Nace Zidar, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2007
Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysisBasil Hartzoulakis, Sharon Rossiter, Herpreet Gill, et al.
The Journal of Biological Chemistry|March 4, 2006
Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signalingHaiyan Jia, Azadeh Bagherzadeh, Basil Hartzoulakis, et al.
Chembiochem : a European Journal of Chemical Biology|April 29, 2014
N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activityHaiyan Jia, Rehan Aqil, Lili Cheng, et al.
Journal of Medicinal Chemistry|February 16, 2010
Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interactionAshley Jarvis, Charles K Allerston, Haiyan Jia, et al.
Pageof 1